DaVita Posts $3.58B in Revenue for Third Quarter 2026
DaVita Inc. reported consolidated revenues of $3.578 billion for Q3 2026, the company announced from its Denver headquarters.
DaVita Inc. (NYSE: DVA) disclosed its financial results for the third quarter ended September 30, 2026, reporting consolidated revenues of $3.578 billion, the kidney care company announced Wednesday from Denver.
The quarterly earnings release marks another reporting period for one of the largest providers of dialysis services in the United States, which operates a broad network of outpatient treatment centers across the country and internationally.
Read more Securitize Acquires River One to Bridge Stablecoins and Asset-Backed Finance →
The company's top-line revenue figure reflects the scale of DaVita's operations serving patients with chronic kidney disease and end-stage renal disease, a patient population that requires regular, ongoing treatment sessions. Demand for dialysis services has remained a structural driver of the company's business model.
Full details of operating income, net earnings, and per-share figures were included in the company's formal release, offering investors and analysts a complete picture of DaVita's profitability and cost management during the quarter.
Continue reading at Earnings for the full breakdown of DaVita's Q3 2026 operating income, margins, and forward guidance.
